TG Therapeutics Inc XNAS: TGTX

Expensive Performer

Download real time

29.78 0.45 (1.53%)

35.93% Fall from 52W High

1.5M

XNAS Volume

XNAS 02 Sep, 2025 3:53 PM (EDT)

TG Therapeutics Inc quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents